Covered recipient · General Payments record
BETSY R WINNEKENS
Allopathic & Osteopathic Physicians Surgery
General Payments · PY2021–2024
$1,060.90
- Reported across 49 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $207.89 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $70.91 | 3 |
| ABBVIE INC. | $54.13 | 2 |
| Integra LifeSciences Corporation | $29.68 | 1 |
| Novo Nordisk AS | $29.27 | 1 |
| Octapharma USA, Inc. | $23.90 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.89 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106348700 | CMS |
| ABBVIE INC. | $28.24 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106348702 | CMS |
| Integra LifeSciences Corporation | $29.68 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140079558 | CMS |
| Novo Nordisk Inc | $29.27 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108565551 | CMS |
| Octapharma USA, Inc. | $23.90 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142324054 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $26.28 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137845402 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $22.75 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137845404 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.88 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137845406 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.